Inhibitors of PI 3-kinase and MEK kinase differentially affect mediator secretion from immunologically activated human basophils
Open Access
- 1 June 1999
- journal article
- Published by Wiley in Journal of Leukocyte Biology
- Vol. 65 (6) , 883-890
- https://doi.org/10.1002/jlb.65.6.883
Abstract
Effects of inhibitors of PI 3-kinase and MEK kinases were investigated on histamine, leukotriene C4 (LTC4), and cytokine release from human basophils stimulated with anti-IgE. The PI 3-kinase antagonists wortmannin (> 10 nM) and LY 294002 (> 1 μM) strongly inhibited anti-IgE-induced release of all mediators by 40–100%. This was contrasted by the effects of the MEK kinase inhibitor PD 098059, which weakly inhibited histamine, interleukin (IL)-4, and IL-13 release but was substantially more efficacious at blocking LTC4 production (> 70% at 10 μM). Previous studies have shown that arachidonic acid synthesis is controlled by MEK kinases. We observed that wortmannin, LY 294002, and PD 098059 reduce basophil ERK-1,2 activation, thus implying that, with regard to arachidonic acid metabolism, MEK kinases are a downstream target for PI-3-kinase. Our results demonstrate a universal regulatory role played by PI 3-kinases in basophil mediator production and release, whereas MEK kinase signaling is largely limited to controlling arachidonic acid metabolism. J. Leukoc. Biol. 65: 883–890; 1999.Keywords
This publication has 0 references indexed in Scilit: